Robert Croce, Chairman of the Vascular Therapies Board of Directors

Chairman of the Board

Robert Croce joined VT’s Board of Directors following a 36 year career at Johnson & Johnson where he held a series of senior positions, culminating with 12 years as Company Group Chairman. Previously, he was Worldwide Franchise Chairman of Cordis, a Johnson & Johnson company.

Prior to that, he was Worldwide Franchise Chairman for Ethicon Endo-Surgery. Mr. Croce began his career with Johnson & Johnson as a Sales Representative for Ortho Pharmaceuticals, where he was named Vice President of Marketing. In 1985, Mr. Croce moved to McNeil Pharmaceutical as Vice President of Business Development. He later transferred to Ethicon, Inc. as Group Vice President, where he remained until he was named President in 1990. In 1992 he was promoted to Worldwide President, Ethicon Endo-Surgery. Mr. Croce also serves on the Board of Directors of Neotract, MoxiMed, ExploraMed/NC7, Earlens, Svelte Medical, and Guided Delivery Systems.

Mr. Croce received his undergraduate and graduate degrees from Central Missouri University.